Better Long-Term Buy: This Emerging Player or the Industry Leader? [Yahoo! Finance]
Abivax SA - American Depositary Shares (ABVX)
Company Research
Source: Yahoo! Finance
well known for its work in immunology, a field in which it boasts some of the best-selling therapies. However, many smaller drugmakers are trying to break into this space. One of them, Abivax (NASDAQ: ABVX) , has grabbed quite a few headlines of late thanks to a potentially transformative immunology medicine still in development. Should investors opt for the well-established giant or the up-and-coming challenger? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » AbbVie made its name in immunology thanks to medicines like Humira, a therapy that was once the world's best-selling drug. Although it has now lost patent exclusivity, AbbVie's lineup also includes Skyrizi and Rinvoq, two immunosuppressants approved across a range of indications, including ulcerative colitis, eczema, plaque psoriasis, Crohn's disease, rheumatoid arthritis, and more. In the first six mon
Show less
Read more
Impact Snapshot
Event Time:
ABVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABVX alerts
High impacting Abivax SA - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ABVX
News
- Prediction: This Healthcare Stock Could Soar by 72% in 2026 [Yahoo! Finance]Yahoo! Finance
- Abivax (NASDAQ:ABVX) had its price target raised by analysts at Morgan Stanley from $101.00 to $145.00. They now have an "overweight" rating on the stock.MarketBeat
- Abivax (NASDAQ:ABVX) was given a new $131.00 price target on by analysts at Oppenheimer Holdings, Inc..MarketBeat
- Abivax (NASDAQ:ABVX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Abivax (NASDAQ:ABVX) had its "buy" rating reaffirmed by analysts at BTIG Research.MarketBeat